Cleveland Biolabs, Inc. (CBLI) Misses Q4 EPS by 2c

Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q4 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $1.95 million versus the consensus estimate of $1 million.

For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Cisco rating cut at HSBC as analyst sees a lack of catalysts
• Movano (MOVE) Misses Q2 EPS by 195c